Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection

American Journal of Respiratory Cell and Molecular Biology

Volumn 51, Issue 4, 2014, Pages 502-515

  Kolli, Deepthi ^a   Gupta, Meera R ^a   Sbrana, Elena ^a   Velayutham, Thangam S ^a   Chao, Hong ^a   Casola, Antonella ^a   Garofalo, Roberto P ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alveolar macrophages; Human metapneumovirus; Pathogenesis; Respiratory syncytial virus; Viral infection

Indexed keywords

HUMAN METAPNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS;

AUTACOID; CYTOKINE;

AIRWAY OBSTRUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; LUNG; LUNG ALVEOLUS MACROPHAGE; METABOLISM; METAPNEUMOVIRUS; PARAMYXOVIRUS INFECTION; PATHOGENICITY; PATHOPHYSIOLOGY; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TIME; VIROLOGY; VIRUS REPLICATION;

AIRWAY OBSTRUCTION; ANIMALS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION MEDIATORS; LUNG; MACROPHAGES, ALVEOLAR; METAPNEUMOVIRUS; MICE, INBRED BALB C; PARAMYXOVIRIDAE INFECTIONS; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TIME FACTORS; VIRUS REPLICATION;

EID: 84907527845     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0414OC     Document Type: Article

References (49)

1. Kahn JS. Human metapneumovirus: A newly emerging respiratory pathogen. Curr Opin Infect Dis 2003;16:255-258.
2. Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, Bergeron MG, Dery P. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003;9:634-640.
3. Edwards KM, Zhu Y, Griffin MR, Weinberg GA, Hall CB, Szilagyi PG, Staat MA, Iwane M, Prill MM, Williams JV; New Vaccine Surveillance Network. Burden of human metapneumovirus infection in young children. N Engl J Med 2013;368:633-643.
4. Hahn A, Wang W, Jaggi P, Dvorchik I, Ramilo O, Koranyi K, Mejias A. Human metapneumovirus infections are associated with severe morbidity in hospitalized children of all ages. Epidemiol Infect 2013; 141:2213-2223.
5. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001;7:719-724.
6. Rivera R, Hutchens M, Luker KE, Sonstein J, Curtis JL, Luker GD. Murine alveolar macrophages limit replication of vaccinia virus. Virology 2007; 363:48-58.
7. Pribul PK, Harker J, Wang B, Wang H, Tregoning JS, Schwarze J, Openshaw PJ. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol 2008;82:4441-4448.
8. Benoit A, Huang Y, Proctor J, Rowden G, Anderson R. Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV). Clin Exp Immunol 2006;145:147-154.
9. Reed JL, Brewah YA, Delaney T, Welliver T, Burwell T, Benjamin E, Kuta E, Kozhich A, McKinney L, Suzich J, et al. Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis. J Infect Dis 2008;198:1783-1793.
10. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich H-J, Van Rooijen N, Gatalica Z, Garofalo RP. Respiratory syncytial virusinduced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis 2002;186:1199-1206.
11. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 2003;167:171-179.
12. Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldonk MJ, Verbon A, van Deventer SJ, van der Poll T. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 2001;166: 4604-4611.
13. Leemans JC, Thepen T, Weijer S, Florquin S, van Rooijen N, van de Winkel JG, van der Poll T. Macrophages play a dual role during pulmonary tuberculosis in mice. J Infect Dis 2005;191:65-74.
14. McGill J, Van Rooijen N, Legge KL. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med 2008;205:1635-1646.
15. Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989;170:499-509.
16. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005;79:14933-14944.
17. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
18. Jakubzick C, Tacke F, Llodra J, van Rooijen N, Randolph GJ. Modulation of dendritic cell trafficking to and from the airways. J Immunol 2006;176:3578-3584.
19. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993;177:397-407.
20. Wijburg OL, DiNatale S, Vadolas J, van Rooijen N, Strugnell RA. Alveolar macrophages regulate the induction of primary cytotoxic Tlymphocyte responses during influenza virus infection. J Virol 1997; 71:9450-9457.
21. Kolli D, Bao X, Liu T, Hong C, Wang T, Garofalo RP, Casola A. Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells. J Immunol 2011;187: 47-54.
22. Ueba O. Respiratory syncytial virus: I. Concentration and purification of the infectious virus. Acta Med Okayama 1978;32:265-272.
23. Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo RP. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998;72:4756-4764.
24. Kisch AL, Johnson KM. A plaque assay for respiratory syncytial virus. Proc Soc Exp Biol Med 1963;112:583-589.
25. Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, Garofalo RP. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J Virol 2001;75:878-890.
26. Kolli D, Bataki EL, Spetch L, Guerrero-Plata A, Jewell AM, Piedra PA, Milligan GN, Garofalo RP, Casola A. Tlymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol 2008;82: 8560-8569.
27. Guilliams M, Lambrecht BN, Hammad H. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol 2013;6:464-473.
28. Lipscomb MF, Pollard AM, Yates JL. A role for TGF-beta in the suppression by murine bronchoalveolar cells of lung dendritic cell initiated immune responses. Reg Immunol 1993;5:151-157.
29. Thepen T, Kraal G, Holt PG. The role of alveolar macrophages in regulation of lung inflammation. Ann N Y Acad Sci 1994;725: 200-206.
30. Takabayshi K, Corr M, Hayashi T, Redecke V, Beck L, Guiney D, Sheppard D, Raz E. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 2006;24:475-487.
31. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003;19:641-644.
32. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK. Mouse interleukin-12 (IL- 12) p40 homodimer: A potent IL-12 antagonist. Eur J Immunol 1995; 25:200-206.
33. Walter MJ, Kajiwara N, Karanja P, Castro M, Holtzman MJ. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001;193:339-351.
34. Wang SZ, Bao YX, Rosenberger CL, Tesfaigzi Y, Stark JM, Harrod KS. IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 2004;173: 4040-4049.
35. Chakraborty K, Zhou Z, Wakamatsu N, Guerrero-Plata A. Interleukin- 12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection. PLoS ONE 2012;7: e37173.
36. Gunsten S, Mikols CL, Grayson MH, Schwendener RA, Agapov E, Tidwell RM, Cannon CL, Brody SL, Walter MJ. IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection. Immunology 2009;126: 500-513.
37. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011;179:248-258.
38. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. Macrophage inflammatory protein 1-alpha, and not T-helper type 2 cytokines, is associated with severe forms of bronchiolitis. J Infect Dis 2001;184:393-399.
39. Newcomb DC, Boswell MG, Reiss S, Zhou W, Goleniewska K, Toki S, Harintho MT, Lukacs NW, Kolls JK, Peebles RS Jr. IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax 2013;68:717-723.
40. Michaeloudes C, Chang PJ, Petrou M, Chung KF. Transforming growth factor-b and nuclear factor E2-related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma. Am J Respir Crit Care Med 2011;184:894-903.
41. Thornburg NJ, Shepherd B, Crowe JE Jr. Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection. J Virol 2010;84: 12895-12902.
42. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, Aozasa K, Kawai T, Akira S. Alveolar macrophages are the primary interferonalpha producer in pulmonary infection with RNA viruses. Immunity 2007;27:240-252.
43. Smit JJ, Rudd BD, Lukacs NW. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006;203:1153-1159.
44. Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO, Durbin RK, Flaño E, Durbin JE. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 2007;81:9790-9800.
45. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 2002;168:2944-2952.
46. Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A, Garofalo RP. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol 2005;79:10190-10199.
47. Stadnyk AW, Gillan TL, Anderson R. Respiratory syncytial virus triggers synthesis of IL-6 in BALB/c mouse alveolar macrophages in the absence of virus replication. Cell Immunol 1997;176:122-126.
48. Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol 2013;191:1250-1259.
49. Ferreira CSA, Frenzke M, Leonard VHJ, Welstead GG, Richardson CD, Cattaneo R. Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J Virol 2010;84:3033-3042.